Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Eskilstuna – page 3

41 clinical trials in Eskilstuna, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Eskilstuna at a glance
41
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

41 trials in Eskilstuna

Open in trial search

Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Mannitol
  • Sponsor:Region Stockholm – SLSO

Colorectal cancer

Not yet recruiting

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet

Ischaemic stroke

Not yet recruiting

Study on Imatinib for Improving Recovery in Patients with Acute Ischemic Stroke

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Karolinska Institutet

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Study of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Altizide
  • Sponsor:Region Uppsala

Hypertriglyceridaemia

Not recruiting

Study on the Safety of A24110He for Patients with Type 2 Diabetes and High Triglycerides

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:A24110HE
  • Sponsor:Lipigon Pharmaceuticals AB

Hypercholesterolaemia

Not recruiting

Study on Evolocumab for Reducing Cardiovascular Events in Patients with Acute Myocardial Infarction

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Facial paresis

Not recruiting

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Sponsor:Region Dalarna

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Eskilstuna

What the registry says about research in the country

01 Cardiovascular and Neurological Studies

Innovative research exploring treatments for acute ischemic stroke, with trials testing new therapeutic approaches within critical time windows. Studies also examine stroke prevention in patients with atrial fibrillation and chronic kidney disease.

  • Stroke Treatment Development
  • Cardiovascular Prevention
  • Renal Complications

Focused on improving patient outcomes through targeted interventions and preventive strategies.

02 Oncology Research

Comprehensive studies in breast cancer treatment optimization, including hormone therapy strategies and targeted treatments for HER2-positive cases. Additional research covers glioblastoma and melanoma management.

  • Advanced Breast Cancer Therapies
  • Brain Cancer Treatment
  • Immunotherapy Applications

Evaluating innovative treatment approaches for various cancer types and stages.

03 Surgical and Infectious Disease Studies

Investigation of infection prevention in hip arthroplasty procedures and research on treating resistant urinary tract infections. Studies focus on improving surgical outcomes and addressing antimicrobial resistance.

  • Surgical Innovation
  • Infection Control
  • Antibiotic Resistance

Developing effective strategies against surgical complications and resistant infections.

04 Women's Health and Obstetrics

Clinical research examining labor induction methods, comparing outpatient versus inpatient approaches to enhance maternal care and outcomes.

  • Labor Management
  • Patient Care Settings
  • Maternal Safety

Focused on optimizing childbirth experiences while maintaining safety standards.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.